Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,015 | 541 | 99.9% |
| Education | $12.00 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,016 | 89 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $793.86 | 46 | $0 (2024) |
| Lilly USA, LLC | $743.97 | 57 | $0 (2024) |
| PFIZER INC. | $611.16 | 40 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $572.44 | 37 | $0 (2024) |
| Novo Nordisk Inc | $545.67 | 43 | $0 (2024) |
| Amgen Inc. | $323.01 | 14 | $0 (2024) |
| Abbott Laboratories | $306.94 | 16 | $0 (2024) |
| Amarin Pharma Inc. | $279.44 | 16 | $0 (2022) |
| Eisai Inc. | $268.85 | 18 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $886.00 | 51 | ABBVIE INC. ($139.75) |
| 2023 | $1,049 | 75 | ABBVIE INC. ($340.91) |
| 2022 | $1,056 | 64 | ABBVIE INC. ($242.86) |
| 2021 | $1,287 | 87 | AbbVie Inc. ($275.94) |
| 2020 | $1,079 | 74 | Lilly USA, LLC ($156.05) |
| 2019 | $762.30 | 57 | Novo Nordisk Inc ($130.04) |
| 2018 | $807.61 | 56 | AstraZeneca Pharmaceuticals LP ($187.08) |
| 2017 | $1,100 | 80 | AstraZeneca Pharmaceuticals LP ($181.22) |
All Payment Transactions
544 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: PAIN | ||||||
| 11/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes Care | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Inflammation | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Diabetes Care | ||||||
| 09/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: DIABETES | ||||||
| 09/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: DIABETES | ||||||
| 07/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: DIABETES | ||||||
| 07/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes Care | ||||||
| 07/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Diabetes Care | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $14.62 | General |
| Category: Medical Device | ||||||
| 05/21/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,118 | 2,842 | $300,114 | $95,800 |
| 2022 | 33 | 2,426 | 3,349 | $342,296 | $103,998 |
| 2021 | 32 | 2,478 | 3,353 | $318,241 | $113,161 |
| 2020 | 34 | 2,551 | 3,402 | $305,030 | $100,865 |
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 3 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 12 | 23 | $1,035 | $375.69 | 36.3% |
| 84466 | Transferrin (iron binding protein) level | Office | 2022 | 17 | 20 | $1,000 | $252.21 | 25.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 55 | 260 | $1,820 | $187.68 | 10.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 12 | 13 | $557.50 | $171.34 | 30.7% |
| 82746 | Folic acid level, serum | Office | 2022 | 11 | 11 | $869.00 | $160.23 | 18.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $988.00 | $128.53 | 13.0% |
| 83540 | Iron level | Office | 2022 | 17 | 20 | $780.00 | $127.92 | 16.4% |
| 84100 | Phosphate level | Office | 2022 | 27 | 27 | $648.00 | $126.95 | 19.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 11 | 13 | $682.50 | $116.00 | 17.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 38 | 48 | $696.00 | $104.98 | 15.1% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2022 | 13 | 15 | $397.50 | $39.98 | 10.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 252 | 353 | $75,955 | $25,644 | 33.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 193 | 193 | $42,460 | $24,849 | 58.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 215 | 374 | $53,840 | $22,993 | 42.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 127 | 128 | $8,320 | $8,304 | 99.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 31 | 31 | $10,075 | $5,150 | 51.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 229 | 300 | $31,500 | $3,168 | 10.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 48 | 50 | $5,000 | $2,566 | 51.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 15 | 15 | $2,850 | $2,497 | 87.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 113 | 136 | $11,696 | $2,285 | 19.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 163 | 168 | $15,120 | $2,250 | 14.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 130 | 131 | $4,585 | $2,156 | 47.0% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 16 | 16 | $2,160 | $1,807 | 83.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 119 | 183 | $11,163 | $1,769 | 15.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 195 | 219 | $10,512 | $1,702 | 16.2% |
About Dr. Blane Graves, MD
Dr. Blane Graves, MD is a Family Medicine healthcare provider based in Texarkana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1124010301.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Blane Graves, MD has received a total of $8,027 in payments from pharmaceutical and medical device companies, with $886.00 received in 2024. These payments were reported across 544 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($8,015).
As a Medicare-enrolled provider, Graves has provided services to 9,573 Medicare beneficiaries, totaling 12,946 services with total Medicare billing of $413,824. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Texarkana, TX
- Active Since 08/16/2005
- Last Updated 09/24/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1124010301
Products in Payments
- FARXIGA (Drug) $627.58
- VRAYLAR (Drug) $606.60
- UBRELVY (Drug) $365.99
- TRADJENTA (Drug) $331.91
- EMGALITY (Drug) $291.65
- Vascepa (Drug) $279.44
- ELIQUIS (Drug) $276.41
- Saxenda (Drug) $264.88
- TRULICITY (Drug) $256.71
- JARDIANCE (Drug) $216.40
- REXULTI (Drug) $213.46
- XARELTO (Drug) $212.89
- CONTRAVE (Drug) $195.10
- CHANTIX (Drug) $195.00
- FREESTYLE LIBRE 3 (Device) $190.05
- QULIPTA (Drug) $183.29
- Belviq (Drug) $163.29
- TRINTELLIX (Drug) $153.80
- Aimovig (Biological) $149.59
- NURTEC ODT (Drug) $130.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Texarkana
Gregory Richter, Md, MD
Family Medicine — Payments: $11,589
Dr. Claudia Jordan, M.d, M.D
Family Medicine — Payments: $9,473
Paul Gardial, M.d, M.D
Family Medicine — Payments: $8,603
Herman Kile, Md, MD
Family Medicine — Payments: $7,630
Mr. James Sarrett, Md, MD
Family Medicine — Payments: $7,382
Kevin O'sullivan, M.d, M.D
Family Medicine — Payments: $6,155